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Abstract
Protein O-fucosylation is an essential post-translational modification, involved in the folding of target proteins and in the
role of these target proteins during embryonic development and adult tissue homeostasis, among other things. Two
different enzymes are responsible for this modification, Protein O-fucosyltransferase 1 and 2 (POFUT1 and POFUT2,
respectively). Both proteins have been characterised biologically and enzymatically but nothing is known at the molecular
or structural level. Here we describe the first crystal structure of a catalytically functional POFUT1 in an apo-form and in
complex with GDP-fucose and GDP. The enzyme belongs to the GT-B family and is not dependent on manganese for
activity. GDP-fucose/GDP is localised in a conserved cavity connected to a large solvent exposed pocket, which we show is
the binding site of epidermal growth factor (EGF) repeats in the extracellular domain of the Notch Receptor. Through both
mutational and kinetic studies we have identified which residues are involved in binding and catalysis and have determined
that the Arg240 residue is a key catalytic residue. We also propose a novel SN1-like catalytic mechanism with formation of an
intimate ion pair, in which the glycosidic bond is cleaved before the nucleophilic attack; and theoretical calculations at a
DFT (B3LYP/6-31+G(d,p) support this mechanism. Thus, the crystal structure together with our mutagenesis studies explain
the molecular mechanism of POFUT1 and provide a new starting point for the design of functional inhibitors to this critical
enzyme in the future.
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Introduction
Protein O-fucosylation is an important post-translational modifi-
cation first reported 36 years ago which is mediated by two
glycosyltransferases, Protein O-fucosyltransferase 1 (POFUT1) and
Protein O-fucosyltransferase 2 (POFUT2) [1,2]. Both enzymes are
inverting glycosyltransferases classified in the CAZy database as
GT65 and GT68, respectively [3]. An enzymatic assay for POFUT1
was described in 1998 [4] and the gene was cloned in 2001 [5].
Genetic experiments confirmed POFUT1 is essential during
development in both flies and mice [6–8] and the phenotypes of
the null embryos demonstrated that it is implicated in the Notch
signalling pathway. The identity and characterisation of POFUT2
was published later in 2006 and confirmed the existence of these two
different glycosyltransferases involved in Protein O-fucosylation
[9,10].
This modification only occurs in eukaryotic organisms and is a
rare form of O-linked glycan on cysteine-rich proteins motifs [11–
13]. Both POFUT1 and POFUT2 act on proteins containing the
cysteine-rich motifs as the acceptor sugar and GDP-fucose as the
donor [4,10]. While POFUT1 activity is increased in the presence
of metals [4], POFUT2 does not require a metal for catalysis [10].
Unlike the majority of glycosyltransferases, which are localised in
the Golgi apparatus, both enzymes reside in the endoplasmic
reticulum. However, while POFUT1 contains the typical endo-
plasmic reticulum localisation sequence, ‘‘RDEF’’ [14], this is not
present in the POFUT2 sequence [10].
The most recognised substrates of POFUT1 are the EGF
repeats present in the extracellular domain of Notch proteins
[5,11,14,15]. Notch is a membrane-anchored signalling receptor
which plays very pleiotropic and essential roles during the
development of many tissues including regulation of cell fate,
proliferation, apoptosis, differentiation and migration [16]. The
extracellular domain of Notch harbours 36 EGF repeats in
mammals; of those, 23 contain a tetrasaccharide unit in which the
first sugar is a fucose [16–18], and 20 contain a trisaccharide unit
in which the first sugar is a glucose [19]. EGF repeats are small
(,40 amino acids) cysteine-rich motifs with six conserved cysteines
forming three disulphide bridges [20,21]. POFUT1 a-fucosylates
serines or threonines present in EGF repeats containing the
appropriate consensus sequence, C
2-X(4-5)-[S/T]-C
3, where C
2
and C
3 are the second and third conserved cysteines. Of these
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biologically since this is the region to which the Notch ligands bind
[22–23]. As mentioned before, fucose is the first residue of a
tetrasaccharide found in some EGF repeats followed by an N-
Acetyl glucosamine (GlcNAc) residue catalysed by the glycosyl-
transferase Fringe proteins [24–25]. This GlcNAcylation together
with Protein O-fucosylation has been shown to be essential in
different organisms. The role of GlcNAc is to mediate or increase
the interaction of Notch with its ligands [24–25]. An additional
role of POFUT1 as a chaperone in the folding and secretion of
Notch is inferred from disruption studies in flies [8–26], unlike in
mice, where similar studies do not support this role [27].
Notch is up-regulated in a large number of diseases such as T cell
acute lymphaticleukaemia(T-ALL) [28] and adult T-cell leukaemia
[29]. Thus the development of pharmacological inhibitors against
POFUT1 may provide an alternative strategy to treat these diseases
through attenuation of Notch signalling pathway.
Less is known about POFUT2. It recognises a second type of
cysteine-rich motif, known as a thrombospondin type 1 repeat
(TSR), which contains six conserved cysteines and three disulphide
bonds [30]. Literature reports to date would suggest that there are
more than 40 proteins affected by this modification, including
thrombospondin 1 and 2, the ADAM family of metalloproteases
and properdin [31–32]. So far the main role of POFUT2 has been
suggested to be involved in secretion of different proteins [31–32].
Despite considerable interest in the role of these proteins during
Notch signalling in embryogenesis, we do not know anything
about the crystal structure of these enzymes or how they recognise
their substrates or what catalytic mechanism these enzymes
employ to modify their target proteins.
In order to address these issues, we describe the first crystal
structure of a eukaryotic POFUT1, in native form and in complex
with GDP-fucose and GDP. The structures show the typical GT-B
folding and a non-metal dependency. Surface electrostatic
potential plus docking studies with POFUT1 and human EGF12
(HsEGF12) suggest the EGF repeat binding site. Furthermore,
through site directed mutagenesis experiments we propose the
catalytic and binding residues involved in Protein O-fucosylation.
Interestingly we also suggest the role of a conserved Arg240 as a
key catalytic residue, which facilitates the glycosidic cleavage that
occurs prior to proton transfer of the acceptor substrate to the
catalytic base, b-phosphate. This work provides a molecular
framework for further studies towards POFUT1 specificity and for
the design of novel POFUT1 inhibitors.
Results and Discussion
Caenorhabditis elegans POFUT1 (CePOFUT1) is a
catalytically functional enzyme which is not dependent
on manganese for activity
CePOFUT1 was identified and selected by a protein blast search
from different organisms. Unlike its homologues in other species it
lacks N-glycosylation sites [33] (Figure 1). This protein showed
,41% identity with higher eukaryote enzymes (Figure 1),
suggesting it functions as a protein O-fucosyltransferase 1. Based
on a multiple alignment (Figure 1), we expressed a truncated
form of CePOFUT1 (amino acids 26–382, excluding the signal
sequence and the retention endoplasmic reticulum localisation
sequence, Figure 1) as a secreted protein in Pichia pastoris and we
purified it by a HiTrap-Blue, ion exchange and by gel filtration
chromatography (see Materials and Methods). POFUT1s
have been shown to bind GDP-fucose and EGF repeats, and
transfer this monosaccharide into small EGF repeats producing
GDP during the reaction. Moreover manganese has been shown
to increase the transfer activity of these glycosyltransferases on
EGF repeats [4,5]. In order to test the binding of CePOFUT1 to
GDP-fucose/GDP and manganese, we conducted a thermal shift-
assay [34] and isothermal titration calorimetry experiments
(Figure 2A and 2B). The protein showed a denaturation
temperature T0 of 50.0760.09uC, which was increased to 2.2
and 4.2uC by incubation of the enzyme with 1 mM GDP-fucose
and GDP, respectively (Figure 2A and Table 1), suggesting
Figure 1. Multiple sequence alignment of POFUT1s. Multiple sequence alignment of the GT65 family members CePOFUT1, HsPOFUT1, Gallus
gallus POFUT1 (GgPOFUT1), Danio renio POFUT1 (DrPOFUT1) and DmPOFUT1. Secondary structure elements from the CePOFUT1 structure are shown,
with a-helices in red and green for the N and C-terminal domains, respectively, and b-strands correspondingly in blue and cyan. Signal sequence of
CePOFUT1 is highlighted in green while endoplasmic reticulum retention sequence for all POFUT1s are indicated in a pink box. Conserved cysteines
forming disulphide bridges and N-glycosylated sites are shown in yellow and magenta, respectively. The boundaries of the N and C-terminal
CePOFUT1 constructs are indicated in red for Thr26 and Ala382.
doi:10.1371/journal.pone.0025365.g001
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calorimetry titrated by different concentrations of the ligands
(Figure 2B) confirmed quantitatively the thermal denaturation
data rendering a Kd (dissociation constant) of 0.2360.04 mM for
GDP-fucose (which is in the low mM range and similar to the Kms
of 4 and 6.4 mM reported for Drosophila melanogaster and mouse
POFUT1 [4,5], respectively) and 0.3560.07 mM for GDP
(Table 2). Since both GDP-fucose and GDP bind with a similar
affinity to the enzyme, inhibition by-products may occur as has
been described for other types of glycosyltransferases [35,36]. As
expected for a highly negatively charged ligand, the binding
energy is dominated, for example in the case of GDP, by a large
negative entalphic term (DH= 210.3760.22 kcal/mol) com-
pared to a non-favoured entropic term (T*DS=21.6 kcal/mol).
Furthermore, in both GDP-fucose and GDP, the stochiometry
observed experimentally was in agreement with a single binding
site. Unlike nucleotides, experiments with 5 mM MnCl2 both with
and without GDP-fucose showed small decreases of 0.25–0.45uC
in the DTm compared to the wild type enzyme (Figure 2A),
indicating that manganese may slightly decrease the stability of
CePOFUT1.
To evaluate the enzymatic properties of CePOFUT1, we
characterised its activity as a glycosylhydrolase and glycosyltrans-
ferase. The hydrolase activity was measured by an enzymatic
coupled assay with NDPase, rendering a specific activity value of
9068 pmol/min*mg in the presence of 100 mM GDP-fucose. We
also determined the activity of CePOFUT1 in the presence of 1
and 5 mM MnCl2, showing that the enzyme is inhibited by
manganese (between 40–60% inhibition, data not shown),
contrary to what has previously been described [4]. The
transferase activity assay was carried out with the enzyme, GDP-
fucose and Mus musculus EGF12 (MmEGF12) from the mouse
Notch1 receptor protein, and determined by MALDI mass
spectrometry (Figure 2C). Strikingly an expected increase of
146 Daltons was obtained in the fucosylated peptide, in
accordance to a fucose bound to MmEGF12 (Figure 2C).
Therefore, CePOFUT1 is a Protein O-fucosyltransferase 1 which
acts independantly of manganese and which recognises the EGF12
repeat from mouse Notch1.
CePOFUT1 adopts a GT-B fold
CePOFUT1 is classified in the CAZy database [3] as GT65.
Currently there is no available data for the structure or folding
properties of this protein. To determine the structure of
CePOFUT1 we obtained three different crystal forms. Due to
the reproducibility and diffracting properties of crystals-form-II
(see Materials and Methods), we solved the structure from a
highly redundant crystal-form-II, previously soaked with MnCl2,
by sulphur SAD experiments, in combination with phase
extension from a crystal co-crystallised with GDP and soaked
with GDP-fucose/MnCl2 diffracting at high resolution (Figure 3A
and Table 3 for data collection and refinement statistics).
Iterative model building and refinement yielded an initial model
which was used to solve crystal-form-I and III with good
refinement statistics (R=0.234, Rfree=0.252 for native crystal-
form-I and R=0.204, Rfree=0.244 for crystal-form-III in complex
with GDP, Table 3). Soaking experiments of crystal-form-I and II
with GDP-fucose yielded a complex to 1.96 A ˚ (R=0.218,
Rfree=0.267, Table 3) and 1.91 A ˚ (R=0.202, Rfree=0.237,
Table 3).
CePOFUT1 is a monomeric protein, as determined by gel
filtration chromatography and confirmed by analytical ultracen-
trifugation (data not shown). This protein is composed of two
Figure 2. Biophysical characterisation of CePOFUT1. (A). Thermal denaturation curves of the wild type enzyme as monitored by ANS
fluorescence in the absence or presence of 5 mM MnCl2, 1 mM GDP-fucose/GDP and 1 mM GDP-fucose together with 5 mM MnCl2.( B). ITC
experiments of wild type enzyme on GDP-fucose and GDP. (C). MALDI-TOF MS of MmEGF12 as a control and incubated with wild type enzyme and
GDP-fucose. The mass of MmEGF12 and fucosylated MmEGF12 are indicated by arrows.
doi:10.1371/journal.pone.0025365.g002
Table 1. T0 and DTm of mutants compared with wild type
enzyme.
T0 (6C)
DTm (6C)
1m MG D P
DTm (6C)
5 mM GDP
DTm (6C)
1 mM GDP-
fucose
Wild Type 50.0760.09 4.21 6.17 2.19
R40A 50.9460.11 0.85 2.71 -
N43A 51.0760.17 2.04 - 1.20
F199A 48.0460.13 2.94 - -
R240A 52.7760.10 0.1 0.09 -
R240K 50.9260.05 1.04 1.27 -
D242A 48.0460.14 6.81 - -
D244A 48.5260.08 4.58 - -
W245A 49.0260.15 0.80 2.19 -
F261A 48.7760.13 4.50 - 1.84
D309N 45.8260.15 5.01 - -
F357A 49.6560.16 0.15 0.90 -
The T0s represent means6S.D. for three independent experiments.
doi:10.1371/journal.pone.0025365.t001
Table 2. GDP-fucose/GDP dissociation constants of mutants
compared with wild type enzyme.
Kd (mM)
GDP
Kd (mM)
GDP-fucose
Wild Type 0.3560.07 0.2360.04
R40A 3.1060.53 -
N43A 0.3060.09 -
F199A 0.1860.03 -
R240A nd -
R240K 61.2610.5 -
D242A 0.0960.02 -
D244A 0.1060.01 -
W245A 1.6060.40 -
F261A 0.1260.07 -
D309N - -
F357A 26.965-
The Kds were determined from thermodynamic relationships and the estimated
errors were less than624% in the majority of the cases. n.d. = not detected;
- = not determined.
doi:10.1371/journal.pone.0025365.t002
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higher eukaryotic POFUT1s (Figure 1 and 3A). The N and the
C-terminal domains (a1- a9/b1- b8 and a10- a19/b9- b13,
respectively) adopt Rossmann-like folds, which are formed by a
central b-sheet surrounded by a-helices on both sides and these
constitute the typical signature of a GT-B fold. The donor sugar,
GDP-fucose, is localised in the interface where the two domains
face each other; a typical signature of glycosyltransferases adopting
the GT-B fold (Figure 3A). The residues from the active site
interacting with GDP-fucose are mainly from the C-terminal
domain (Figure 3A) together with a few from the N-terminal
domain. Glycosyltransferases adopting GT-B folds are metal-
independent [37] and this characteristic is further supported by
the thermal denaturation curves and kinetic experiments shown
above (Figure 2 and 3). A structure search on the DALI [38]
server revealed not surprisingly structural homology with two
other fucosyltransferases, nodulation fucosyltransferase [39]
(NodZ) (RMSD [Root mean square deviation] on 231 equivalent
Cas= 4.1 A ˚) and a-1,6 fucosyltransferase or FUT8 [40] (RMSD
on 222 equivalent Cas= 3.7 A ˚), which also contain the typical
GT-B fold. The structure with the third highest Z score was ADP-
heptose LPS heptosyltransferase II (RMSD on 184 equivalent
Cas= 3.8 A ˚) (PDB ID 1PSW), which folds as a GT-B and is
functionally different to fucosyltransferases.
A comparison among the different crystal forms revealed minor
conformational changes within the two domains (RMSD of 0.25 A ˚
among apo crystal-form-I and soaked with GDP-fucose, and 0.66–
0.86 A ˚ among crystal-form-I compared to crystal-form-II and III,
respectively) and some differences in order/disorder loop changes,
such as a loop in the N-terminal domain (residues 125–134). The
larger RMSD could have resulted from differences in crystal
packing and not from bound ligands due to the small RMSD
among crystals-form-I with and without the ligand.
CePOFUT1 contains four conserved disulphide bridges through
the GT65 family (Figure 1 and 3A), two in each domain. The
first one, placed in a loop connecting b1 and a1 and formed by
Cys35 and Cys37 (Figure 3A), is an unusual disulphide bridge
due to the proximity between both cysteines and represents a
signature of the all family (Figure 1). This loop contributes to
form the sugar donor-binding site together with residues from a1
and it is possible that this disulphide bridge helps to correctly
position them. The second one is formed between Cys139 from b6
and Cys135 placed in a loop preceding a7. This disulphide occurs
in the vicinity of disordered loops and it is possible that it helps to
limit flexibility. Cys249 and Cys281 form the third disulphide,
which comes from the a11 and a14, respectively. a11 and the
previous loop contribute to the sugar donor binding site with key
amino acids (Figure 1 and 3A). The fourth disulphide, formed by
Cys266 and Cys353, comes from the a12 and the loop between
b12 and a19, respectively. Amino acids in the loop preceding a12
contribute to the sugar donor-binding site (Figure 1 and 3A).
CePOFUT1 is a good representative of the GT65 family
The crystal structure and the high identity between CePOFUT1
and the sequence of POFUT1 in higher eukaryotics (identity
$41%), implies structural conservation of GT65 family members
(Figure 1 and 3B) and suggests that the sugar donor binding site
may be completely conserved (Figure 1 and 3B). Furthermore
GDP-fucose points out to a very conserved solvent exposed pocket,
in which EGF repeats are expected to bind (Fig. 3B and 4). To
confirm the binding site of EGF repeats, we analysed the
electrostatic surface potential (Figure 4A) between the HsEGF12
Figure 3. Overall crystal structure of CePOFUT1. (A). 2|Fo |-|Fc | electron density maps for the region around the first disulphide bridge, Cys35-
Cys37. 2|Fo |- |Fc |, fcalc electron density maps are shown at 1.0 s. The upper map was obtained from initial phases from SHELXC/D/E [52] while the
map below corresponded to improved phases obtained from phase extension (see Materials and Methods). (B). Overall crystal structure of
CePOFUT1 in complex with GDP-fucose. Secondary structure elements from the CePOFUT1 structure are shown, with a-helices in red and green for
the N and C-terminal domains, respectively, and b-strands correspondingly in blue and cyan. The four disulphide bridges are highlighted in yellow.
GDP-fucose is shown as sticks with black carbon atoms for illustration purposes. (C). Surface representation of the CePOFUT1, colored by sequence
conservation ((pink (100% identity), to grey (,50% identity)). GDP-fucose is shown as sticks with green carbon atoms.
doi:10.1371/journal.pone.0025365.g003
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that sugar nucleotide donor and the acceptor binding site were
overall positive while EGF12 was negatively charged (Figure 4A),
suggesting electrostatic complementarity between both proteins.
Furthermore, docking studies with ClusPro [41] were carried out
to confirm binding site and orientation of the EGF repeats (see
Materials and Methods, and Figure 4B). EGF repeats
contain two antiparallel b-strands and the glycosylated Ser/Thr
residues preceding the third cysteine are localised at the beginning
of the first b-strand. We analysed the 30 top structures returned by
ClusPro (the HsEGF12 was located in the pocket mentioned above
in all of the output structures), and we selected two complexes
(Figure 4B) based on the Thr466 orientation with respect to the
sugar nucleotide GDP-fucose. Surprisingly, in only one of these
two complexes, Thr466 OG1 is 5 A ˚ from the fucose anomeric
carbon, suggesting not only the right localisation but also the right
orientation of HsEGF12. Furthermore, Thr466 is facing the sugar
from the a-face, which is compatible with the inverting character
of POFUT1.
Therefore CePOFUT1 provides a useful tool with which to
understand the catalytic mechanism of GT65 family members and
to provide a platform to develop future inhibitors against human
POFUT1 in order to treat diseases in which Notch signalling
activity is up-regulated [28,29], due to its high structural identity
with the human enzyme.
GDP-fucose is bound in a conserved cavity formed
mainly by amino acids from the C-terminal domain
The four crystal structures described in the current manuscript
represent three different steps during catalysis (Figure 5 and
Figure S1). The first two structures were obtained by crystals-
form-I. One of them represents the apo-form bound to a sulfate
molecule in the active site, while the second structure is bound to
GDP-fucose resembling the substrate binding mode. The third one
is a crystal-form-II, in complex with GDP-fucose (also resembling
the substrate binding mode), which contains amino acids in the
active site with different conformational changes in relation to the
above structure. The fourth one is a crystal-form-III in complex
with GDP, resembling a product complex. In the structures
complexed with ligands, GDP-fucose and GDP occupied identical
positions (Figure 5). The nucleotide was localised between a1,
a18, a19, b10, b12 and loops among b1- a1, a15- b10, b11- a18
and b12- a19 (Figure 5). While guanosine and fucose adopt
favourable conformations, the pyrophosphate group of GDP-
fucose/GDP shows torsion angles (a, b, c are 61u,4 8 u, and 22u,
respectively) distorted from ideal angles, which are 180
o
(Figure 5). Unusual torsion angles are also found in Helicobacter
pylori a-1,3-fucosyltransferase (HpFucT) in complex with GDP-
fucose [42] (a, b, c are 260u, 138u and 278u, respectively),
suggesting that fucosyltransferases twist pyrophosphate in order to
fit GDP-fucose into their active sites. Due to these changes, two
intra hydrogen bonds are formed in GDP-fucose/GDP, one
between the ribose O3 and the a-phosphate opposite oxygen, and
the second one between fucose O2 and the a-phosphate opposite
oxygen (Figure 5). The guanine ring is sandwiched between
Phe357 and Asp309 by stacking hydrophobic interactions (in the
case of Asp309, a and b carbons of this residue contribute to the
hydrophobic interaction) (Figure 5). The rest of the interactions
with guanine occur through hydrogen bonds with backbones of
Ser308 and Asp234, and side chains of His238 and Asp334
(Figure 5). The ribose ring makes hydrogen bonds with the Arg40
side chain and the Phe41 backbone (Figure 5). The a-phosphate
interacts through hydrogen bonds with the Gly42 and Asn43
backbones while b-phosphate makes hydrogen bonds with the
Ser355, Thr356 and Arg240 side chains and also shows an
additional salt bridge with the latter amino acid (Figure 5). In the
apo structure, a sulphate group occupies the b-phosphate position
found in the complex with GDP-fucose and maintains conserved
interactions with Arg240 and Thr356. The fucose is recognised by
a stacking hydrophobic interaction with Phe261, and hydrogen
bonds through its oxygen ring with Arg240, and O3, O4 with the
Asn43 side chain (Asn43 makes different hydrogen bonds with
fucose depending on its conformations in the crystal structures,
Figure 5). Moreover, there is an additional interaction between
fucose O4 and a water molecule in the b-face (only water
molecules around the fucose binding site will be discussed, just for
clarification purposes), which also interacts with Arg40. Finally, a
second water molecule from the apo structure is present in the
fucose a-face, making hydrogen bonds with sulphate and Asn43.
This water molecule may represent the catalytic incoming water or
Ser/Thr of the EGF repeat (to be discussed later, Figure 5 and
Figure 4. Localisation of EGF repeat binding site in CePOFUT1.
(A). Electrostatic surface representation of CePOFUT1 and HsEGF12 (PDB
code 2VJ3). CePOFUT1 has an overall positive charge in the sugar and
acceptor binding site while HsEGF12 is negatively charged around
Thr466 [56]. GDP-fucose is shown as sticks with green carbon atoms
while Thr466 is indicated by an arrow. (B). Docking of HsEFG12 into
CePOFUT1. CePOFUT1 is represented as a surface model colored by
sequence conservation, while HsEGF12 is shown either as ribbon
representation on the left (b-strands are in blue and the three
disulphide bridges are highlighted in yellow) or as a surface model
(in orange) on the right. GDP-fucose and Thr466 are shown as sticks
with green carbon atoms.
doi:10.1371/journal.pone.0025365.g004
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Asp242, Asp244 and Phe261 in the above mentioned structures
suggesting flexibility in the catalytic region.
Site-directed mutagenesis studies suggest Arg240 as a
key residue involved in binding and catalysis
On the basis of these crystal structures, we evaluated the
importance of several amino acids in the binding and catalytic
properties of this enzyme by site-directed mutagenesis. We
mutated residues involved in binding to guanosine (Phe357,
Arg40, Asp309), pyrophosphate (Arg240), fucose (Asn43, Arg240
and Phe261) and also around the ligand, but not directly
implicated in binding such as Phe199, Trp245, Asp242 and
Asp244. Phe199 was close to Asn43 and Phe261, while Trp245
was hydrophobically stacked to Arg240. Inverting glycosyltrans-
ferases requires an aspartic, glutamic acid or histidine as a catalytic
base to deprotonate an incoming acceptor substrate in order to
attack the anomeric carbon bound to the nucleotide [43].
Figure 5. Active site of CePOFUT1 apo-form and in complexes with GDP-fucose/GDP. Stereo view of the active site of CePOFUT1 apo-form,
in complex with GDP-fucose and GDP. The amino acids placed in the active site are shown as sticks with grey carbons. GDP-fucose and GDP are
represented as stick models with green carbon atoms. Protein-ligand and water-ligand hydrogen bonds are shown as dotted black lines. Only water
molecules localised in the fucose binding site are shown for clarity purposes. Water molecules are shown as cyan spheres. b and a faces of fucose are
indicated to understand the stereochemistry of the catalytic reaction. Unbiased (i.e. before inclusion of any ligand model) |Fo |- |Fc |, fcalc electron
density maps are shown at 2.2 and 2.5 s.
doi:10.1371/journal.pone.0025365.g005
Figure 6. Site-directed mutagenesis, superposition study and proposed catalytic mechanism. (A). Glycosylhydrolase activity assay of
mutants compared with that of the wild type enyme. The activity of mutants is shown as relative to the wild type enzyme (being 100%). The data
represent means6S.D. for six to nine independent experiments. (B). Superposition of a GDP-fucose complex into the apo-form structure. Asn43,
Arg240, Trp245 and Phe261 are shown as sticks with grey carbons. GDP-fucose is represented as stick models with green carbon atoms. A water
molecule localised in the a-face is shown as a cyan sphere. Dotted hydrogen bonds between Asn43 and Arg240 from the apo structure and sulphate
are shown as grey while the same amino acids from the complex and GDP-fucose are shown as black. Asn43, Arg240, Trp245 and Phe261 from both
structures superpose with a RMSD of 0.21 A ˚, 0.77 A ˚, 0.91 A ˚ and 0.29 A ˚, respectively. Sulphate of apo structure mimics b-phosphate of GDP-fucose
because adopts an analogous position. (C). SN1-like catalytic mechanism with formation of an intimate ion pair in the transition state. R in blue is the
hydrogen of a water molecule or the rest of the incoming EGF repeat. Arg240 and Asn43 are in green, GDP is in red, fucose is in black and the
incoming acceptor substrate is in blue. The proton transferred during the reaction is in blue. Protein-ligand and incoming acceptor substrate-ligand
hydrogen bonds are shown as dotted black lines.
doi:10.1371/journal.pone.0025365.g006
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Asp242 and 244, which were close to the sugar donor binding site.
We firstly characterised them by thermal denaturation curves,
showing two different groups of amino acids, both less and more
stable than the wild type. R40A, N43A and R240A/K were more
stable while F199A, D309N, D242A, D244A, W245A, F261A and
F357A were less stable (Table 1). We further incubated them with
increasing concentrations of GDP to compare the DTm with that
of the wild type in the same conditions (Table 1). F199A, D242A,
D309N, D244A, F261A showed increases similar to the wild type
at 1 mM GDP; N43A was half of the wild type DTm; while R40A,
R240A/K, W245A and F357A had less than 4-fold reduction in
the DTm. DTm of the latter mutants was increased with 5 mM
GDP except for R240A, which did not show any significant
change. Finally both mutants, N43A and F261A, had a decrease in
DTm at 1 mM GDP-fucose compared to that of the wild type
(Table 1). These results suggest that mutated amino acids with
less increase in the DTm compared to the wild type, may show
decreased binding to the nucleotide. In order to confirm this
hypothesis, we further evaluated the binding of these mutants by
ITC experiments. All the mutants were titrated with GDP. Three
different groups of mutants were found in relation to the binding
of GDP. N43A and F199A bound to GDP with similar Kd
(Table 2) to the wild type, in accordance with a non direct
interaction of these amino acids with the nucleotide (Figure 5). A
second group of mutants such as R40A, R240A/K, W245A and
F357A showed a decrease in binding to GDP (Table 2). From this
group, R40A and W245A bound better to GDP than F357A,
R240K and R240A, with the latter being impaired in binding
under our conditions (see Table 2 and Materials and
Methods). These results suggest that Arg40 and Trp245 may
have an important structural role in the active site, while Phe357
and Arg240 are critical amino acids in binding to the nucleotide
(Figure 5). A third group, which includes mutants such as D242A,
D244A and F261A, showed 3-fold improvement in binding,
although none of these residues interact directly with GDP.
On the other hand we evaluated the hydrolase activity of these
mutants on GDP-fucose (Figure 6A). D309N and D242A showed
a very similar activity to the wild type enzyme while D242A,
R40A, F199A, D244A, F261A and F357A displayed a slight
decrease in activity. Finally the activity of W245A and N43A was
diminished 12.5 and 25-fold, respectively, while R240A/K were
impaired catalytically (Figure 6A). These results suggest that the
majority of the mutated amino acids may affect activity due to
changes in their ability to bind the nucleotide or due to their
influence in the nature of the folding of the active site. Only
Asn43, Arg240 and Trp245 were critical for activity.
Catalytic mechanism
To our surprise, the activity data with D242A and D244A
suggested that the enzyme may not have any amino acid acting as a
catalytic base. Unlike Asp242 or Asp244, Arg240 played an
important key role in binding and catalysis. Under the conditions
assayed, R240A was completely impaired with respect to binding to
GDP while R240K was 175-fold decreased with respect to binding
toGDP.R240KmayhavebetterbindingthanR240AsinceR240K
may mimic the positive charge present in Arg240. Strikingly,
although R240K showed a reduced binding to GDP, the activity
was completely abolished. Our data with Arg240 are supported by
mutagenesisstudiesofan equivalent Arg245inDrosophilamelanogaster
POFUT1 (DmPOFUT1, Figure 1) which is also present in a-1,2
and a-1,6 fucosyltransferases. In these enzymes, mutations of this
key arginine also impaired the activity [44-46]. Therefore Arg240
(Arg245 in DmPOFUT1) plays a conserved and critical function in
POFUT1 which is also extended to other fucosyltransferases.
A detailed analysis of the active sites of the crystal structures
(Figure 5), together with a superposition of the GDP-fucose
complex on the apo structure (Figure 6B), suggests that Arg240,
through a hydrogen bond with the glycosidic bound oxygen, may
facilitate the cleavage of the glycosidic bond. The stacking
hydrophobic interaction between Arg240 and Trp245 may
explain the decreased affinity and activity of W245A. Finally,
Asn43 is a flexible amino acid involved in binding to fucose
(Figure 5) and it is also important in catalysis. The superposed
structures show that Asn43 may be critical in positioning the
incoming water or Ser-Thr residue of the EGF repeat in order for
catalysis to take place. Certainly this suggestion would fit with our
data showing its importance in catalytic activity. Based on the
superposition study we also propose b-phosphate as the catalytic
base due to a possible hydrogen bond with the incoming water/
Ser-Thr of the EGF repeat (see hydrogen bond between sulphate
and water molecule in the apo structure, Figure 5). Thus, the
model would be that the cleavage of the glycosidic bond would
take place first; and an oxocarbenium ion would be formed
leading to a transition state with an ion pair. In this scenario,
Arg240 should maintain the salt bridge and hydrogen bond to b-
phosphate but not to the fucose ring oxygen, in order for the
oxocarbenium ion to be stable (Arg240 would make the
oxocarbenium ion unstable if the interaction was maintaned).
Furthermore, the b-phosphate group would associate closely with
the incipient oxocarbenium ion blocking the upper face and
allowing the backside attack of the incoming acceptor substrate.
This mechanism is also favoured by the concomitant proton
transfer from the acceptor substrate to the phosphate group as
illustrated in Figure 6C. The cleavage of the glycosidic bond
before the attack to the anomeric carbon has been also suggested
for an inverting a-1,3 fucosyltransferase V [47].
In order to support this proposal, we explored the mechanism of
the reaction by using DFT methods at a B3LYP/6-31+G(d,p) level
(see Materials and Methods, and Figure S2 and S3). the
transition structure TS-1 was located after an exploration of the
potential energy surface guessed as a function of the predefined
reaction coordinates based on X-ray data. The analysis of the
geometrical change occurring along the reaction pathway
demonstrates that the phosphate-anomeric carbon bond is broken
leading to the formation of an oxacarbenium ion pair with the
concomitant entry of the water molecule and without the
formation of any intermediate. In the transition structure both
geometrical parameters and frequency analysis confirm the above
proposed mechanism. Analyzing the located transition state it is
possible to see the breaking of the bond between the anomeric
carbon and the b-phosphate. The length of such a bond is 1.40 A ˚
in the reactants increasing to 3.18 A ˚ at the TS; however the
oxygen phosphate involved in proton transfer remains at 2.63 A ˚
indicating a stabilizing electrostatic interaction. The attack of the
water molecule is facilitated by the hydrogen bond with the
phosphate group leading to a distance between the water oxygen
and the anomeric center of 2.72 A ˚ at the TS. In this transition
state the proton transfer occurs between the water molecule and
the phosphate group. The role of Arg240 is crucial in order to
stabilize the charge of the incipient free phosphate group thus
promoting its dissociation from the anomeric center.
Concluding Remarks
Despite the biological importance of Protein O-fucosylation as a
post translational modification event in both embryogenesis and
adult homeostasis, there has not been a single study devoted to the
POFUT1 Crystal Structure
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modification event. Furthermore, although POFUT1 and PO-
FUT2 fucosylate a large number of acceptor substrates with
different functions, both enzymes still recognise similar types of
small domains or repeats. Thus, POFUT1 and POFUT2 may
follow a similar folding and catalytic mechanism. In the present
study we have solved the first crystal structure of CePOFUT1, which
serves as a conserved family member.
CePOFUT1 is a catalytically competent non manganese-
dependent enzyme, transfering fucose to MmEGF12. The protein
shows a typical GT-B fold formed by two Rossmann domains. A
cavity for GDP-fucose is localised in the interface between the
domains and a contiguous solvent exposed pocket for EGF repeats
was identified by electrostatic and docking studies. Mutagenesis
studies on several amino acids suggest the importance of Arg240,
Phe261 and Phe357 in binding to the sugar nucleotide, and Asn43
together with Arg240 as important catalytic residues. The absence
of an amino acid as a catalytic base and the presence of a water
molecule interacting with a sulphate in the fucose a-face of the apo
structure, suggest that b-phosphate may represent thecatalytic base.
Thus, we propose that Arg240 facilitates the cleavage of the
glycosidic bond with formation of a oxocarbenium ion, prior to a
proton transfer from the incoming acceptor substrate to the leaving
phosphate and consequently attacking of the acceptor substrate to
the anomeric carbon. In this mechanism Asn43 may position the
hydroxyl group of the incoming substrate close to the b-phosphate.
We further support this mechanism by means of theoretical
calculations at a DFT level, which clearly indicated the formation
of an ion pair at the transition state, between the incipient
oxocarbenium ion and the phosphate group, in which the charge
transfer is facilitated by the residue Arg240. The reaction can be
considered to follow a SN1-like mechanism even though the proton
transfer between the water and the phosphate group takes place
with the entry of the nucleophile and the formation of the ion pair,
and without formation of any intermediate.
Furthermore these studies may represent a significant advance for
the design and development of future compounds which may be useful
to treat diseases in which Notch signalling activity is up-regulated.
Materials and Methods
Cloning, expression and purification
The DNA sequence encoding amino acid residues 26–382 of
the Caenorhabditis elegans CePOFUT1 (swissprot: locus OFUT1_
CAEEL; accession Q18014; GeneID: C15C7.7), defined as
cepofut1, was made synthetically and codon optimized by Gen-
Script for expression in Pichia pastoris. The DNA, containing at the
59 end a recognition sequence for XhoI and a KEX2 cleavage
signal and at the 39 end a sequence for SacII, was cloned into the
pUC57 vector (GenScript). Following digestion with XhoI and
SacII the cloned sequence was subcloned into the Pichia pastoris
protein expression and secretion vector pPICZaA (Invitrogen),
resulting in the expression plasmid pPICZaAcepofut1 (T26-A382).
The plasmid pPICZaAcepofut1 (T26-A382), referred to here as
the wild type, was used as a template for introducing the following
single amino acid changes by site-directed mutagenesis: R40A,
N43A, F199A, R240K, R240A, D242A, D244A, W245A, F261A,
D309N, F357A, such that each of the resulting 11 plasmids carried
the indicated mutation. Site-directed mutagenesis was carried out
following the ‘QuikChange’ kit protocol (Stratagene), using the
KOD HotStart DNA polymerase (Novagene). All plasmids were
verified by sequencing (Sistemas Geno ´micos, Servicio de Secuen-
ciacio ´n; www.sistemasgenomicos.com).
All plasmids were isolated from the E. coli strain DH5a,
linearised with SacI and used to transform the Pichia pastoris strain
into X-33 by electroporation. Transformants were selected on
YPD plates (1% (w/v) yeast extract, 2% (w/v) peptone, 2% (w/v)
dextrose) containing 100 mg/ml of zeocin (InvivoGen). Batch
cultures were performed in 100 ml volume of BMGY medium
(1% (w/v) yeast extract, 2% (w/v) peptone, 100 mM potassium
phosphate (pH 6.0), 1.34% (w/v) yeast nitrogen base and 1% (v/v)
glycerol). 50 ml were used to grow 500 ml of BMGY medium
overnight at 30uC and expression was induced by methanol (1%,
v/v) for 72–96 h at room temperature in a shaking incubator (270
rpm). Yeast cells were harvested by centrifugation at 3480 g for
30 min. The supernatants containing soluble CePOFUT1 were
filtered to 0.45 and 0.2 mm, concentrated to 20–50 ml using a
Pellicon XL device (10,000 MWCO, PES membrane; Millipore)
and dialyzed against 25 mM Tris pH 8.5.
The samples were then loaded onto a 165 ml HiTrap Blue
Sepharose (Amersham Biosciences) that had been equilibrated
with 10 column volumes of 25 mM Tris pH 8.5 on an AKTA
purifier system. Following loading, the column was washed with 10
column volumes of 25 mM Tris pH 8.5. The protein was eluted
with a salt gradient (0–1 M NaCl) over 15 column volumes,
collecting 3 ml fractions. The fractions containing the proteins
were then pooled and dialyzed against 25 mM Tris pH 8.5.
The dialysed sample was loaded onto a 165 ml HiTrap Q FF
column (Amersham Biosciences) that had been equilibrated with
10 column volumes of 25 mM Tris pH 8.5 on an AKTA purifier
system. Following loading, the column was washed with 10
column volumes of 25 mM Tris pH 8.5. The protein was eluted
with a salt gradient (0–1 M NaCl) over 15 column volumes,
collecting 3 ml fractions. The fractions containing the proteins
were then pooled and concentrated to 2.5 ml using centrifugal
filter units of 10,000 MWCO (Millipore). Subsequently, gel
filtration was carried out using a Superdex 75 XK26/60 column
in 25 mM Tris, 150 mM NaCl, pH 8.5. The concentrated
CePOFUT1 protein, previously dialysed in 25 mM Tris pH 8.5,
was used for both kinetic analysis and crystallization trials.
Thermal shift ligand binding assays
To monitor the binding of ligands to CePOFUT1, the thermal-
shift assay was performed. The method is based on the observation
that ligands change protein thermal stability upon binding to the
protein. This results in a change of the midpoint temperature for
the thermal protein unfolding transition, Tm.
The protein unfolding process is monitored using the environ-
mentally sensitive dye 1-anilino-8-naphthalene sulfonate (ANS). Its
quantum yield increases upon binding to hydrophobic surfaces
exposed during protein unfolding and so does the fluorescence
signal.
The thermal-shift assay was conducted in the FluoDia T70
(Photal Otsuka Electronics). Solutions of 2 mM CePOFUT1,
100 mM ANS, 20 mM HEPES pH 7.0, and 200 mM NaCl final
concentration and a volume of 100 ml were added to the wells of a
96-well PCR plate. Mineral oil was last added to avoid
evaporation during the experiment. The final concentration of
the ligands were: GDP-fucose/GDP at 1 and 5 mM, MnCl2 at
5 mM, and GDP-fucose with MnCl2 at 5 mM. Mutants were also
evaluated under the same conditions.
Data were analysed with the Origin software. To obtain Tm,a
Boltzmann model from Origin was used to fit the fluorescence
imaging data:
I=( A +B ((B-A)/(1+exp (Tm-T)/C))
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pretransitional and posttransitional fluorescence intensities, re-
spectively, and C is a slope factor.
Data points after the fluorescence intensity maximum were excluded
from fitting. In the absence of ligands, Tm=T0, and the ligand-
dependent changes in midpoint temperature, DTm=Tm2T0,c o u l db e
calculated for each ligand.
Isothermal titration microcalorimetry (ITC)
ITC was used to evaluate the dissociation constants of
CePOFUT1 and mutants against GDP-fucose and GDP. All
experiments were carried out at 25uC with concentrations of
CePOFUT1 and mutants between 10 and 30 mM, and concen-
trations of GDP-fucose and GDP between 150 mM and 1 mM, in
25 mM Tris, pH 7.5.
The reactions were performed on an AUTO ITC instrument
Microcal Auto-iTC200. Data integration, correction and analysis
were carried out using Origin 7 (Microcal) with a single-site
binding model.
Hydrolysis of GDP-fucose by CePOFUT1
CePOFUT1 activity was assayed by testing its ability to
hydrolyse GDP-fucose. 5 mM CePOFUT1 was incubated with
100 mM GDP-fucose and 0.01 mg/ml NTPDase 3 (R&D Systems)
in 25 mM Tris, 5 mM CaCl2, pH 7.5 to a final volume of 36 ml.
Mixtures were incubated for 3 and 20 hours at 25uC. The reaction
was stopped by heating the samples at 80uC for 10 min. Release of
inorganic phosphate was measured with the Malachite Green
Phosphate Detection kit (R&D Systems) and the absorbance was
read at 620 nm with a microplate reader from Biotek sinergy HT.
100 mM GDP-fucose and 100 mM GDP with 0.01 mg/ml
NTPDase 3 were also assayed as controls. The same protocol
was used to assay CePOFUT1 mutants’ activity.
Mass spectrometry analyses
A folded synthetical MmEGF12 repeat was purchased from JPT
Peptide Technologies GmbH, in order to determine the transfer
activity of CePOFUT1. The MmEGF12 repeat, at ,70% purity,
was incubated with 5 mM CePOFUT1 and 100 mM GDP-fucose in
25 mM Tris, 5 mM CaCl2, pH 7.5, for 20 hours at 25uC. A sample
of MmEGF12 repeat in the same buffer was taken as a control.
The samples were concentrated and desalted by passing them
through ZipTip C18 columns (Millipore) following the manufac-
turer’s instructions and eluting with 70% acetonitrile (ACN), 0.1%
trifluoroacetic acid (TFA) in water.
Sample (0,4 ml) and matrix (0,8 ml saturated solution of alpha-
Cyano-4-hydroxycinnamic acid in 50% ACN, 0.1% TFA in water)
were spotted in duplicate onto a Opti-Tof 384 well insert plate
(Applied Biosystems). MALDI-TOF MS was performed using a
4800plus MALDI-TOFTOF (Applied Biosystems) in the reflector
negative mode with accelerating voltage of 20 kV, mass range of
1000 to 5000 Da, 500 shots/spectrum and laser intensity of 2800.
Spectra were calibrated externally using bovine insulin (+2) m/z
2867,8, bovine insulin (+1) m/z 5734,6.
Crystallization and data collection
CePOFUT1 was spin-concentrated to 30 mg/ml. Three different
crystal forms corresponding to two different space groups (Table 3)
were grown by sitting drop experiments at 18uC through mixing
1 ml of protein with an equal volume of a reservoir solution. Native/
apo crystals, belonging to C2 space group (crystal-form-I), were
obtained in 100 mM BIS-TRIS, 2 M ammonium sulphate, pH 6.0.
The other C2 crystals (crystal-form-II) obtained by cocrystallisation
among the protein and 5 mM GDP were grown from 100 mM
HEPES, 100 mM MgCl2, 20% PEG3350, pH 7.5. To obtain the
second space group, P65 (crystal-form-III), the protein was
cocrystallised as described above, and crystals were produced from
a solution containing 100 mM HEPES, 2% PEG 400, 1.8 M
ammonium sulphate, pH 6.5. The crystals grown in ammonium
sulphate were cryoprotected with saturated lithium sulphate, while
the ones grown in PEG3350 were cryoprotectedinthe same mother
liquor plus 35% PEG3350, and flash cooled prior to data collection
at 100 K. GDP-fucose complex was generated by soakings of native
andcrystal-form-IIswith10–100 mMGDP-fucose inmotherliquor
for 10–20 minutes prior to data collection (crystal-form-II at high
resolution was also soaked with 100 mM MnCl2). The latter crystal
soaked with this high concentration of metal contains a manganese
atom localised in the fucose position and appears to be coordinated
by b-phosphate group oxygen atom of GDP together with two
water molecules (Figure S1). We think that this is probably an
artefact due to the high amount of the metal used and thus does not
have any significant function.
Highly redundant sulphur SAD and a native crystal soaked with
GDP-fucose data were collected in house on a Bruker microsource
with a Kappa goniometer and an Axiom detector, all other data
were collected at beamline BM16 and ID23-1 (ESRF, Grenoble).
All data were processed and scaled using the XDS package [48],
the PROTEUM suite and CCP4 software [49], relevant statistics
are given in Table 3.
Structure determination and refinement
By sulphur single anomalous diffraction (SAD) phasing method-
ology, using highly redundant data from a crystal cocrystallised with
GDP (Table 3) and using the software pipeline Auto-Rickshaw
[50,51], SHELXC/D/E [52] identified 17 sites, yielding initial
phases to resolution 2.6 A ˚. Iterative phase improvement was
conducted with an isomorphous high resolution data set of crystal-
form-II at 1.54 A ˚ to generate initial maps (to be described
elsewhere), from which a model for the apo structure was built with
ARP/warp [53] (initially building 315 out of 346 residues of the
single protein monomer in the asymmetric unit) and improved
through cycles of manual model building in Coot [54] and
refinement with REFMAC5 [49]. Molecular replacement with this
structure as a search model was used to generate phases and starting
models for the remaining data sets, which were refined as described
above. Topologies for the oligosaccharide ligands were generated
with SKETCHER [49] (part of the CCP4 software). The final
models were validated with PROCHECK [55], model statistics are
given in Table 3. Coordinates and structure factors have been
deposited in the Worldwide Protein Data Bank (wwPDB) under
accesion codes 3ZY2, 3ZY3, 3ZY4, 3ZY5 and 3ZY6.
Rigid Body Docking
TheCePOFUT1crystalstructure was used forrigidbodydocking
together with HsEGF12 structure obtained form the pdb 2VJ3 [56].
The fully automated online docking program ClusPro was used to
dock the structure [41]. The PDB file for the CePOFUT1 crystal
structure was submitted as the receptor structure, whereas the PDB
file of an HsEGF12 was submitted as the ligand structure. The
selected docking program was PIPER, which uses a clustering
radius of 9 A ˚ and provides 1000 low energy structures [41,57–59].
The top 30 structures were returned and only one of them was
selected based on the orientation with GDP-fucose bound to
CePOFUT1. Images were generated using PyMOL.
Theoretical Calculations
All calculations were conducted using the DFT method, using
the B3LYP functional as implemented in Gaussian 09 [60]. The
POFUT1 Crystal Structure
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31+G(d,p). Frequency calculations were conducted to characterize
transition state, reagents and products, as well as to use as a basis
for determining free energy values at 298 K. Geometry
optimizations and vibrational analyses were performed without
any coinstraint. On the basis of the existing structural data and to
reduce computational cost, a model maintaining the fundamental
characters of the real reaction system has been chosen. We used
the simplest model with one phosphate unit, which is involved in
proton transfer and nucleophilic attack and the presence of the
fundamental residue Arg240, modelled as a guanidine unit
involved in hydrogen bonding with the phosphate unit. The
calculated reaction coordinates are illustrated in Figure S2 and
the located transition structure TS-1 in Figure S3.
As discussed in the manuscript, the calculated reaction pathway
and the located transition structure confirm the hypothesis
outlined from X-ray data. The crucial Arg240 promotes the
initial bond breaking between the phosphate group and the
anomeric center by forming an incipient oxacarbenium ion, which
is stabilized in the form of a ion-pair formed through pivotal of the
phosphate unit to approximate the second oxygen atom involved
in proton transfer with the nucleophile. Such a situation is favored
by the presence of Arg240 which stabilizes the negative charge
formed at the oxygen atom previously linked to the anomeric
carbon, in addition to a hydrogen bond with the hydroxyl group at
C-2 of the fucose unit. Simultaneously, Arg240 goes far from the
endocyclic fucose oxygen atom to allow the charge displacement
responsible of the formation of an electrophilic anomeric center
and, at the same time, the nucleophile approximates such
anomeric carbon bringing out the proton transfer to the phosphate
group. This situation is captured in the located transition structure
TS-1 thus supporting the initial hypothesis concerning the
formation of an intimate ion pair in the transition state as well
as the only need of the intrinsic phosphate group to promote the
reaction.
Supporting Information
Figure S1 Stereo view of the active site of the high
resolution dataset of CePOFUT1 in complex with GDP.
The amino acids placed in the active site are shown as sticks with
grey carbons. The density suggests the presence of GDP, GDP-
fucose and a manganese atom. Due to a partial density for fucose
(see black arrows), we decided to include two molecules of GDP.
GDP are represented as stick models with green carbon atoms.
Manganese is shown as brown sphere and appears to be
coordinated by b-phosphate group oxygen atom and two water
molecules. Protein-ligand and water-ligand hydrogen bonds are
shown as dotted black lines. Only water molecules localised in the
fucose binding site are shown for clarity purposes. Water
molecules are shown as cyan spheres. Unbiased (i.e. before
inclusion of any ligand model) |Fo |- |Fc |, fcalc electron density
map is shown at 2.5 s.
(TIF)
Figure S2 Calculated Reaction Coordinate.
(TIF)
Figure S3 Optimized transition structure at a B3LYP/6-
31+G** level.
(TIF)
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